Expression of vascular endothelial growth factor by human renal cancer cells enhances angiogenesis of primary tumors and production of ascites but not metastasis to the lungs in nude mice

Clinical and Experimental Metastasis

Volumn 17, Issue 10, 1999, Pages 831-840

  Kanayama, Hiro Omi ^a   Yano, Seiji ^a   Kim, Sun Jin ^a   Ozawa, Shutaro ^a   Ellis, Lee M ^a   Fidler, Isaiah J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Renal cell carcinoma; Tumor growth; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER SURVIVAL; CONTROLLED STUDY; DNA TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY CANCER; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; NUDE MOUSE; TUMOR VASCULARIZATION;

ANIMALS; ASCITES; CARCINOMA, RENAL CELL; ENDOTHELIAL GROWTH FACTORS; HUMANS; KIDNEY NEOPLASMS; LUNG NEOPLASMS; LYMPHOKINES; MALE; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; SUBRENAL CAPSULE ASSAY; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033763198     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006792007063     Document Type: Article

References (50)

1. How is blood vessel growth regulated in normal and neoplastic tissue? G.HA Clowes Memorial Award Lecture
2. The implications of angiogenesis for the biology and therapy of cancer metastasis
3. Clinical applications of research on angiogenesis
4. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
5. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
6. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
7. The role of vascular endothelial growth factor in the regulation of blood vessel growth
8. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
9. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinoma
10. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
11. Vascular endothelial growth factor expression is increased in renal cell carcinoma
12. Quantification by competitive quantitative RT-PCR of VEGF121 and VEGFI65 in renal cell carcinoma
13. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
14. Vascular endothelial growth factor platelet counts, and prognosis in renal cancer
15. Renal cell carcinoma: Relevance of angiogenetic factors
16. Serum concentration of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas
17. Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma
18. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice
19. A high conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines
20. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract
21. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
22. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo
23. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms
24. Enhancement of tumor growth and vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells
25. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor
26. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
27. Modulation of in vivo growth of thyroid tumor-derived cell lines by sense and antisense vascular endothelial growth factor gene
28. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
29. Growth and metastasis of tumor cells isolated from a human renal cell carcinoma implanted into different organs of nude mice
30. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells
31. Dowrtregulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src
32. Regulation of distinct steps of angiogenesis by different angiogenic molecules
33. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
34. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
35. Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor
36. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice
37. Inhibition of malignant ascites and growth of human ovarian carcinoma by oral administration of a potent inhibitor of the vascular endothelial growth factor receptor tyrosine kinases
38. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in peritoneal lining
39. Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an antivascular endothelial growth factor/vascular permeability factor antibody
40. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody
41. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: An in vivo study on 29 tumors
42. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors
43. Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted VPF
44. VPF: A protein mediator that induces tumor vessel hyperpermeability and promotes endothelial cell growth
45. VPF/VEGF, microvascular permeability and angiogenesis
46. Vesiculo-vacuolar organelles (VVOs) and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin
47. Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not VEGF189
48. Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein
49. The von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathways
50. Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation